Sotio Biotech Overview
- Year Founded
-
2010
- Status
-
Private
- Employees
-
100
- Latest Deal Type
-
Series A
- (In Progress)
Sotio Biotech General Information
Description
Operator of targeted cancer therapeutics intended to improve the treatment of cancer through precision oncology and immunotherapy approaches. The company offers antibody-drug conjugates and a PD-1 cis-targeted IL-15 immunocytokine, enabling oncology researchers and healthcare providers to access targeted therapies that address limitations of existing cancer treatments.
Contact Information
Website
www.sotio.comCorporate Office
- Ceskomoravska 2532/19b
- Prague 9
- Prague, 190 00
- Czech Republic
Corporate Office
- Ceskomoravska 2532/19b
- Prague 9
- Prague, 190 00
- Czech Republic
Sotio Biotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC (Series A) | 01-May-2026 | In Progress | Clinical Trials - Phase 1 |
Sotio Biotech Comparisons
Industry
Financing
Details
Sotio Biotech Competitors (8)
One of Sotio Biotech’s 8 competitors is Ayala Pharmaceuticals, a Corporation company based in Wilmington, DE.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Ayala Pharmaceuticals | Corporation | Wilmington, DE | ||||
| F-Star Therapeutics | Formerly VC-backed | Cambridge, United Kingdom | ||||
| Agenus | Formerly VC-backed | Lexington, MA | ||||
| Oncorus | Formerly VC-backed | Andover, MA | ||||
| Kite Pharma | Formerly VC-backed | Santa Monica, CA |
Sotio Biotech Patents
Sotio Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026180614-A1 | Anti-cdh17 antibodies | Pending | 27-Feb-2025 | ||
| WO-2026093513-A1 | Anti-lrrc15 antibodies and uses thereof | Pending | 31-Oct-2024 | ||
| WO-2025078686-A1 | Combination therapy involving antibody-drug conjugates against claudin18.2 and pd1/pd-l axis inhibitors for treatment of cancer | Inactive | 12-Oct-2023 | ||
| EP-4694916-A1 | Engineered immune cells for treating cancer in combination with il-2/il-15 receptor ?? agonists | Pending | 14-Apr-2023 | ||
| US-20260284145-A1 | Engineered immune cells for treating cancer in combination with il-2/il-15 receptor beta-gamma agonists | Pending | 14-Apr-2023 | A61K38/1793 |
Sotio Biotech Signals
Sotio Biotech FAQs
-
When was Sotio Biotech founded?
Sotio Biotech was founded in 2010.
-
Where is Sotio Biotech headquartered?
Sotio Biotech is headquartered in Prague, Czech Republic.
-
What is the size of Sotio Biotech?
Sotio Biotech has 100 total employees.
-
What industry is Sotio Biotech in?
Sotio Biotech’s primary industry is Drug Discovery.
-
Is Sotio Biotech a private or public company?
Sotio Biotech is a Private company.
-
What is Sotio Biotech’s current revenue?
The current revenue for Sotio Biotech is .
-
Who are Sotio Biotech’s competitors?
Ayala Pharmaceuticals, F-Star Therapeutics, Agenus, Oncorus, and Kite Pharma are some of the 8 competitors of Sotio Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process